Skip to content
10-Q

Quarterly Report

INNOVATION PHARMACEUTICALS INC.

0001477932-21-007937

← back to feed
Filed
Nov 9, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Nov 4, 2021 437.1M sh
Cash And Equivalents Q1 2022 · Sep 30, 2021 $11.21M
Cash And Equivalents Q1 2022 · Jun 30, 2021 $10.19M
Cash And Equivalents Q1 2022 · Sep 30, 2020 $7.25M
Cash And Equivalents Q1 2022 · Jun 30, 2020 $6.02M
Current Liabilities Q1 2022 · Sep 30, 2021 $6.23M
Current Liabilities Q1 2022 · Jun 30, 2021 $6.54M
Total Liabilities Q1 2022 · Sep 30, 2021 $6.43M
Total Liabilities Q1 2022 · Jun 30, 2021 $6.79M
Current Assets Q1 2022 · Sep 30, 2021 $11.38M
Current Assets Q1 2022 · Jun 30, 2021 $10.69M
Total Assets Q1 2022 · Sep 30, 2021 $14.73M
Total Assets Q1 2022 · Jun 30, 2021 $14.3M
Operating Cash Flow Q1 2022 · Sep 30, 2020 −$1.52M
Stockholders Equity Q1 2022 · Sep 30, 2020 $4.67M
Stockholders Equity Q1 2022 · Jun 30, 2020 $1.46M
Sga Expense Q1 2022 · Sep 30, 2020 $264K
Rd Expense Q1 2022 · Sep 30, 2020 $524K
Net Income Q1 2022 · Sep 30, 2020 −$1.17M
Operating Income Q1 2022 · Sep 30, 2020 −$1.13M
Revenue Q1 2022 · Sep 30, 2020 $0